The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    INTERVIEWKorean adoptee in Germany reunites with birth family after 42 years

  • 3

    Korea to start mass production of KF-21 in 2024

  • 5

    Zoo shares sad story of what caused Sero the zebra to escape

  • 7

    Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'

  • 9

    Daughter of North Korean dictator seen wearing $1,900 Dior jacket

  • 11

    Will Apple Pay launch boost local iPhone sales?

  • 13

    INTERVIEW'Welcome to world of art therapy'

  • 15

    INTERVIEWForbes-listed entrepreneur pursues partnerships with Samsung, LG, SK to help Ukraine

  • 17

    Indonesian students advise Korean bank on entering Indonesian market

  • 19

    Long viewed as an outsider, conceptual artist grabs global spotlight in his twilight years

  • 2

    Zebra captured after escaping from Seoul zoo

  • 4

    Will exempting foreign nannies from minimum wage boost Korea's birth rate?

  • 6

    Yoo Yeon-seok threatens to sue people spreading accusations about him

  • 8

    Sandstorm from China forecast to push up fine dust levels in Korea

  • 10

    Retailers rush to adopt Apple Pay system

  • 12

    INTERVIEWExpert pitches Laotian rural reform to solve NK's chronic food shortages

  • 14

    Kim Nam-gil to embark on Asia fan-meeting tour

  • 16

    Lee Som, Ahn Jae-hong to play married couple in Tving's new series

  • 18

    US Fed lifts key interest rate amid banking sector fears

  • 20

    Samsung, SK chiefs prepare for trips to China amid intensifying 'chip war'

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
  • Tech
  • Bio
  • Companies
Sat, March 25, 2023 | 07:28
Bio
SK Bioscience recruits experts for global expansion
Posted : 2023-01-20 14:40
Updated : 2023-01-24 13:42
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
                                                                                                 Richard Kensinger, left, vice president of R&D project management at SK Bioscience USA, and Kenneth Lee, vice president of biologic business development at SK Bioscience / Courtesy of SK Bioscience
Richard Kensinger, left, vice president of R&D project management at SK Bioscience USA, and Kenneth Lee, vice president of biologic business development at SK Bioscience / Courtesy of SK Bioscience

By Baek Byung-yeul

SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday.

The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch, SK Bioscience USA.

Kensinger has over 20 years of experience in the global bio industry, having served as a global bioprocess expert at global healthcare company Sanofi Pasteur. He also worked as an executive director of process development and protein sciences at Affinivax, which was acquired recently by GSK.

He will be in charge of managing SK's global R&D projects and seeking joint research opportunities with global partners.

SK Bioscience said it expects Kensinger to upgrade its manufacturing process system to a top global level to help it expand into the U.S. bio market.

Given that Korean companies essentially need to earn Current Good Manufacturing Practices (cGMP) certification from the U.S. Food and Drug Administration (FDA), which is considered the most demanding standard in the world, this appointment clearly shows SK Bioscience aims to expand its global competitiveness.

The company also appointed Kenneth Lee as vice president of Biologic Business Development at the company's R&D center in Seongnam, Gyeonggi Province.

Lee previously worked in R&D, business development and M&As at global bio companies such as Gilead Sciences, CrystalGenomics, BioMarin Pharmaceutical, Binex and Samsung Bioepis.

Before joining SK Bioscience, he worked for GenScript Probio, which specializes in cell and gene therapy (CGT) and contract development and manufacturing organization (CDMO) businesses.

"Based on his specialty in CGT, we expect Lee to play a crucial role in securing the CGT platform and discovering non-vaccine bio businesses," the company said.

SK Bioscience anticipates that the recent recruitment of executives who have worked for global biopharmaceutical companies will help improve its capability and help make inroads into the global market including the U.S. and Europe.
Emailbaekby@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Zoo shares sad story of what caused Sero the zebra to escapeZoo shares sad story of what caused Sero the zebra to escape
2Burnout: Cardiothoracic surgery residents work 102 hours a week Burnout: Cardiothoracic surgery residents work 102 hours a week
3North Korea will pay price for reckless provocations, warns Yoon North Korea will pay price for reckless provocations, warns Yoon
4Second daughter of Daesang chairman promoted to vice president Second daughter of Daesang chairman promoted to vice president
5More companies adopt electronic voting amid increase in shareholder activism More companies adopt electronic voting amid increase in shareholder activism
6Churches, Seoul gov't unite to fight low birthrate Churches, Seoul gov't unite to fight low birthrate
7What's next for Do Kwon? What's next for Do Kwon?
8FTC criticized for delaying approval for Hanwha's acquisition of DSME FTC criticized for delaying approval for Hanwha's acquisition of DSME
9Over 70% of firms unwilling to embrace longer workweek Over 70% of firms unwilling to embrace longer workweek
10Samsung Display strike looms due to deadlocked wage negotiationsSamsung Display strike looms due to deadlocked wage negotiations
Top 5 Entertainment News
1Yoo Yeon-seok threatens to sue people spreading accusations about him Yoo Yeon-seok threatens to sue people spreading accusations about him
2Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol' Kim Min-gyu, Go Bo-gyeol bid farewell to 'The Heavenly Idol'
3Kim Nam-gil to embark on Asia fan-meeting tour Kim Nam-gil to embark on Asia fan-meeting tour
4Lee Som, Ahn Jae-hong to play married couple in Tving's new series Lee Som, Ahn Jae-hong to play married couple in Tving's new series
5Long viewed as an outsider, conceptual artist grabs global spotlight in his twilight years Long viewed as an outsider, conceptual artist grabs global spotlight in his twilight years
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group